NextCure, Inc.
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is i…
Biotechnology
US, Beltsville [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
NextCure, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDNextCure, Inc. can't present revenue by segment